13F filing recap · Q2 2020
What did ValueAct Capital buy in Q2 2020?
Reported stock-position changes between this filing and the previous one.
Stock value
$8.74B
Positions
21
Estimated turnover
15.8%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.